Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
It's never too early to think about retirement. Learn when to start planning for your retirement and ensure financial stability.
26,408 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Peloton pivots to the commercial gym market with a new Commercial Series, sending shares higher as it targets gym cha...
The S&P 500 faced renewed selling on March 24, 2026, as traders weighed higher yields and mixed earnings. The stock m...
New York Fed researchers find a widening gap in how households respond to rising gas prices after the Iran-related sh...
The Mortgage Bankers Association reports mortgage demand rises 1.7% in the latest weekly survey, with purchases up an...
Catena Labs, led by Circle cofounder Sean Neville, closes a $30 million Series A to expand AI-driven payments tools a...
A Las Vegas real estate agent says social media became 100% of his client pipeline after one educational video went v...
The ethereum trust (etha) lost roughly half its value in 2026 while a strong payroll print reinforced a risk-off mood...
SpaceX's public debut ignites a rapid sector rotation out of listed space stocks. Virgin Galactic craters 24% as inve...
Gold climbs to record highs while platinum remains weak, spotlighting a little-known platinum ETF that sits at the ce...
World Cup bets on Polymarket surged to $3.3 billion in trading volume, eclipsing the Super Bowl and drawing attention...
In a rare pivot, Xbox's chief executive joins the Federal Reserve’s external AI and jobs task force just days after r...